ClinicalTrials.gg
CompletedNCT03332550LapLavUpdated Apr 20, 2023

A National Study of Clinical Results After Emergency Operation for Perforated Diverticulitis

An observational study in Perforated Diverticulitis, sponsored by Sahlgrenska University Hospital. Completed at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2023-04-20.

Sponsored by Sahlgrenska University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
669
Sex
All
01

Study summary

The aim of this study is to evaluate clinical results and effect on health and well-being in patients operated for perforated diverticulitis with purulent peritonitis by laparoscopic lavage in Sweden when used outside of prospective studies/trials and in comparison with the traditional treatment, i.e. colon resection with or without stoma formation.

A secondary aim is to evaluate the outcome after fecal peritonitis.

The hypothesis is that laparoscopic lavage as treatment for perforated diverticulitis with purulent peritonitis is safe, efficient and cost saving, when used in routine health care.

02

Conditions studied

  • Perforated Diverticulitis

Browse trials for

Keywords

  • laparoscopic lavage
03

In context

Diverticulitis

125 studies on the registry are indexed under Diverticulitis; 22 are open to participants now.

This study's enrollment of 669 is above the median of 275 across 59 observational studies indexed under Diverticulitis.

Browse Diverticulitis studies →

Lead sponsor

Sahlgrenska University Hospital is the lead sponsor of 263 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All swedish patients registrered within the Swedish Patient Registry with ICD 10 codes K57 classified as emergency admissions and with a NOMESCO code JAH01, JFB46 , JFB60, JFB61, JFB63, JAK04, JAW97.

The cohort will be divided into two groups when analysing and presenting results, perforated diverticulitis with purulent peritonitis (Hinchey grade III) and perforated diverticulitis with faecal peritonitis (Hinchey grade IV) .

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients registered in the Patient registry with ICD 10 codes K57 classified as emergency admissions and with the Nordic Medico-Statistical Committee (NOMESCO) code JAH01(diagnostic laparoscopy), JFB46 (resection of sigmoid colon), JFB60 (resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB61 (laparoscopic resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB63 (other colon resection, colostomy and closure of the distal stump), JAK04 (laparoscopy and peritoneal lavage), JAW97 (other laparoscopic operation involving abdominal wall, mesentery, peritoneum or the omentum)

Exclusion criteria

Exclusion Criteria:

  • Patients where hospital records reveal that the index admission was misclassified (not perforated diverticulitis) will be excluded.
  • Patients classified as Hinchey 1-2.
  • No received or withdrawal of consent (questionnaire)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
669 participants (actual)
Patient registry
No

Groups and cohorts

  • purulent peritonitis

    Hinchey 3

    Procedure: Laparoscopic lavage · Procedure: Colon resection

  • faecal peritonitis

    Hinchey 4

    Procedure: Colon resection

Interventions

  • ProcedureLaparoscopic lavage

    Operation with laparoscopic lavage for perforated diverticulitis Hinchey 3

  • ProcedureColon resection

    Operation with colon resection for perforated diverticulitis Hinchey 4

06

What researchers measure

Primary outcomes

  1. Need for further surgical interventions within 12 months of index surgery

    Number of patients in need of further surgical interventions within 12 months after index surgery.

    Time frame: 12 months

Secondary outcomes

  1. Need for further surgical interventions within 24 months of index surgery

    Number of patients in need of further surgical interventions within 24 months after index surgery.

    Time frame: 24 months

  2. Colon cancer diagnosis

    Number of colon cancer diagnosis within 12 months

    Time frame: 12 months

  3. Health economics with regard to the two different treatment modalities.

    In the analysis data from the study will be combined with prices from the cost-per-patient system at Sveriges Kommuner och Landsting, or where appropriate, from Sahlgrenska University Hospital, in combination with sensitivity testing of results.

    Time frame: 2 years

  4. Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively.

    Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively in a national Swedish cohort and in routine health care.

    Time frame: 36 months

  5. Complications (Clavien-Dindo ≥ IIIa) within 90 days of index surgery.

    Complications (Clavien-Dindo ≥ IIIa) within 90 days of index surgery.

    Time frame: 90 days

  6. Mortality (90 days and 12 months respectively).

    Mortality (90 days and 12 months respectively).

    Time frame: 12 months

  7. Patient reported outcome after treatment for perforated diverticulitis, function

    Patient reported outcome as measured using a disease specific questionnaire 2-3 years after index surgery. The questionnaire is developed specifically for this study and will address prevalence, severity and associated distress of symptoms using Likert-type scales regarding function after surgery for perforated diverticulitis.

    Time frame: 3 years

  8. Patient reported outcome after treatment for perforated diverticulitis, quality of life

    Patient reported outcome using a questionnaire sent out 2-3 years after index surgery for perforated diverticulitis, using EQ-5D for quality of life.

    Time frame: 3 years

07

Study locations

1 site
  • Sahlgrenska University Hospital
    Gothenburg, Västa Götaland 413 45, Sweden
08

References and documents

Publications

  • Angenete E, Bock D, Rosenberg J, Haglind E. Laparoscopic lavage is superior to colon resection for perforated purulent diverticulitis-a meta-analysis. Int J Colorectal Dis. 2017 Feb;32(2):163-169. doi: 10.1007/s00384-016-2636-0. Epub 2016 Aug 27. PubMed 27567926 ↗
  • Angenete E, Thornell A, Burcharth J, Pommergaard HC, Skullman S, Bisgaard T, Jess P, Lackberg Z, Matthiessen P, Heath J, Rosenberg J, Haglind E. Laparoscopic Lavage Is Feasible and Safe for the Treatment of Perforated Diverticulitis With Purulent Peritonitis: The First Results From the Randomized Controlled Trial DILALA. Ann Surg. 2016 Jan;263(1):117-22. doi: 10.1097/SLA.0000000000001061. PubMed 25489672 ↗
  • Gehrman J, Angenete E, Bjorholt I, Bock D, Rosenberg J, Haglind E. Health economic analysis of laparoscopic lavage versus Hartmann's procedure for diverticulitis in the randomized DILALA trial. Br J Surg. 2016 Oct;103(11):1539-47. doi: 10.1002/bjs.10230. Epub 2016 Aug 22. PubMed 27548306 ↗
  • Schultz JK, Wallon C, Blecic L, Forsmo HM, Folkesson J, Buchwald P, Korner H, Dahl FA, Oresland T, Yaqub S; SCANDIV Study Group. One-year results of the SCANDIV randomized clinical trial of laparoscopic lavage versus primary resection for acute perforated diverticulitis. Br J Surg. 2017 Sep;104(10):1382-1392. doi: 10.1002/bjs.10567. Epub 2017 Jun 20. PubMed 28631827 ↗
  • Vennix S, Musters GD, Mulder IM, Swank HA, Consten EC, Belgers EH, van Geloven AA, Gerhards MF, Govaert MJ, van Grevenstein WM, Hoofwijk AG, Kruyt PM, Nienhuijs SW, Boermeester MA, Vermeulen J, van Dieren S, Lange JF, Bemelman WA; Ladies trial colloborators. Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial. Lancet. 2015 Sep 26;386(10000):1269-1277. doi: 10.1016/S0140-6736(15)61168-0. Epub 2015 Jul 22. Erratum In: Lancet. 2019 Jun 1;393(10187):2200. doi: 10.1016/S0140-6736(19)31191-2. PubMed 26209030 ↗
  • Thornell A, Angenete E, Bisgaard T, Bock D, Burcharth J, Heath J, Pommergaard HC, Rosenberg J, Stilling N, Skullman S, Haglind E. Laparoscopic Lavage for Perforated Diverticulitis With Purulent Peritonitis: A Randomized Trial. Ann Intern Med. 2016 Feb 2;164(3):137-45. doi: 10.7326/M15-1210. Epub 2016 Jan 19. PubMed 26784672 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03332550
Responsible party
Eva Haglind, MD, PhD, professor (MD, PhD, professor, Sahlgrenska University Hospital) — Principal investigator
First posted
Nov 6, 2017
Start date
Apr 18, 2018
Primary completion
Dec 31, 2020
Completion
Dec 31, 2022
Last update
Apr 20, 2023

Study contacts

Eva Haglind
principal investigator · Sahlgrenska University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion